Your browser is no longer supported. Please, upgrade your browser.
Settings
ENZ Enzo Biochem, Inc. daily Stock Chart
ENZ [NYSE]
Enzo Biochem, Inc.
Index- P/E- EPS (ttm)-0.04 Insider Own8.60% Shs Outstand47.53M Perf Week-3.15%
Market Cap321.30M Forward P/E169.00 EPS next Y0.04 Insider Trans-5.95% Shs Float43.54M Perf Month-13.78%
Income-1.70M PEG- EPS next Q-0.01 Inst Own69.50% Short Float2.02% Perf Quarter-28.77%
Sales109.20M P/S2.94 EPS this Y-105.60% Inst Trans3.68% Short Ratio5.28 Perf Half Y-38.60%
Book/sh1.90 P/B3.56 EPS next Y300.00% ROA-1.60% Target Price12.00 Perf Year2.74%
Cash/sh1.41 P/C4.81 EPS next 5Y- ROE-1.90% 52W Range6.42 - 12.04 Perf YTD-17.06%
Dividend- P/FCF321.30 EPS past 5Y44.40% ROI-3.50% 52W High-43.85% Beta0.73
Dividend %- Quick Ratio4.30 Sales past 5Y0.90% Gross Margin44.40% 52W Low5.30% ATR0.23
Employees433 Current Ratio4.70 Sales Q/Q5.30% Oper. Margin-2.10% RSI (14)33.18 Volatility2.71% 3.53%
OptionableYes Debt/Eq0.00 EPS Q/Q57.20% Profit Margin-1.50% Rel Volume0.69 Prev Close6.80
ShortableYes LT Debt/Eq0.01 EarningsMar 12 AMC Payout- Avg Volume166.52K Price6.76
Recom2.00 SMA20-4.77% SMA50-13.55% SMA200-30.50% Volume115,107 Change-0.59%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Feb-03-18 09:20AM  Top 5 Biotech Stocks for 2018 Investopedia
Jan-22-18 09:00AM  Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test Business Wire
Jan-09-18 07:00AM  Free Post Earnings Research Report: Enzo Biochems Revenue Grew 5%; Net Loss Narrowed ACCESSWIRE
Dec-19-17 07:50AM  Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Dec-13-17 07:00AM  Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas ACCESSWIRE
Dec-11-17 04:53PM  Edited Transcript of ENZ earnings conference call or presentation 8-Dec-17 1:30pm GMT Thomson Reuters StreetEvents
02:46PM  Enzo Biochem (ENZ) Q1 2018 Earnings Conference Call Transcript Motley Fool
10:40AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q1, 2018 By the Numbers : December 11, 2017 Capital Cube
Dec-08-17 07:00AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE -7.57%
Dec-07-17 04:15PM  Enzo Biochem reports 1Q loss Associated Press
04:10PM  Enzo Biochem Reports Improved First Quarter Results Business Wire
01:39PM  ETFs with exposure to Enzo Biochem, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:00AM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T. Business Wire
Oct-24-17 09:37AM  ETFs with exposure to Enzo Biochem, Inc. : October 24, 2017 Capital Cube
Oct-23-17 08:30AM  Enzo Biochem Announces NYS Department of Healths Approval of a New Womens Health Infectious Disease Panel Business Wire
Oct-21-17 06:16PM  What Investors Should Know About Enzo Biochem Incs (ENZ) Financial Strength Simply Wall St.
Oct-13-17 10:45AM  ETFs with exposure to Enzo Biochem, Inc. : October 13, 2017 Capital Cube
Oct-12-17 02:35PM  Top 5 Biotech Stocks for 2017 Investopedia
Oct-10-17 07:00AM  Earnings Review and Free Research Report: Enzo Biochems Q4 and Annual Top-line Rise on a Y-o-Y Basis ACCESSWIRE
Oct-03-17 10:20PM  Edited Transcript of ENZ earnings conference call or presentation 28-Sep-17 12:30pm GMT Thomson Reuters StreetEvents
Oct-02-17 10:49AM  ETFs with exposure to Enzo Biochem, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:09AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q4, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-28-17 01:48PM  Enzo Biochem Inc (ENZ) Files 10-K for the Fiscal Year Ended on July 31, 2017 GuruFocus.com -6.99%
08:16AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bullish Manner : ENZ-US : September 28, 2017 Capital Cube
06:45AM  Investor Network: Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Sep-27-17 09:16PM  Enzo Biochem posts 4Q profit Associated Press +6.02%
04:16PM  Enzo Biochem posts 4Q profit Associated Press
04:05PM  Enzo Biochem Reports Increase in Revenues and Profitable Fourth Quarter Business Wire
Sep-22-17 03:33PM  Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 at 8:30 AM E.T. Business Wire
Sep-01-17 09:52AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bullish Manner : ENZ-US : September 1, 2017 Capital Cube
Aug-25-17 06:52PM  Enzo Biochem, Inc. Value Analysis (NYSE:ENZ) : August 25, 2017 Capital Cube
Aug-17-17 09:04AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bearish Manner : ENZ-US : August 17, 2017 Capital Cube
Aug-14-17 10:37AM  Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern Zacks
Aug-12-17 07:00AM  Edited Transcript of ENZ earnings conference call or presentation 9-Jun-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 04:17PM  Catalyst (CPRX) Posts Narrower than Expected Loss in Q2 Zacks
04:14PM  Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised Zacks
Aug-09-17 02:15PM  Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact Zacks
11:13AM  Orexigen (OREX) Q2 Loss Narrows, Contrave Sales Impress Zacks
11:13AM  Agios (AGIO) Q2 Loss Wider than Expected, Revenues Up Y/Y Zacks
10:53AM  Endocyte (ECYT) Stock Up Despite Wider-than-Expected Q2 Loss Zacks
10:51AM  Achillion (ACHN) Q2 Loss In Line, Gains on Pipeline Update Zacks
Aug-07-17 04:09PM  Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q2 Zacks
Aug-04-17 04:35PM  Juno Therapeutics (JUNO) Q2 Loss Widens, Revenues Surpass Zacks
10:12AM  Agenus (AGEN) Q2 Loss Narrower Than Expected, Revenues Lag Zacks
08:41AM  AMAG Pharma (AMAG) Incurs Narrower-than-Expected Loss in Q2 Zacks
Aug-02-17 10:24AM  Corcept (CORT) Q2 Earnings Beat Estimates, Guidance Raised Zacks
Aug-01-17 08:30AM  Strongbridge Biopharma (SBBP) Rises: Stock Moves 17% Higher Zacks
Jul-31-17 10:44AM  Dr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise Zacks
Jul-28-17 02:33PM  Acorda (ACOR) Q2 Earnings Miss Estimates, Revenues in Line Zacks
09:36AM  Keryx (KERX) Posts Wider than Expected Loss in Q2, Sales Beat Zacks
Jul-27-17 11:27AM  GlaxoSmithKline (GSK) Beats on Q2 Earnings, Lowers Guidance Zacks
11:07AM  Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View Zacks
11:03AM  Alexion (ALXN) Tops Q2 Earnings & Revenues, Ups 2017 View Zacks
Jul-21-17 08:50AM  Galapagos (GLPG) Looks Good: Stock Adds 6.2% in Session Zacks
Jul-20-17 06:19PM  Emergent Inks Agreement to Acquire Anthrax Drug Raxibacumab Zacks
Jul-19-17 10:16AM  Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt Zacks
Jul-18-17 06:12PM  Perrigo Company Gets FDA Approval for Generic Topical Gel Zacks
Jul-17-17 03:11PM  Arena Announces Secondary Stock Worth $150M (revised) Zacks
Jul-14-17 02:35PM  Gilead (GILD) Application for HIV Drug Validated in EU Zacks
08:53AM  Can Enzo Biochem (ENZ) Run Higher on Strong Earnings Estimate Revisions? Zacks
Jul-13-17 06:03PM  BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug Zacks
10:57AM  5 Stocks with Recent Price Strength to Enhance Your Returns Zacks
Jul-12-17 10:13AM  Arena Announces Secondary Stock Offering of 150M Shares Zacks
09:30AM  The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences Zacks
Jul-11-17 05:32PM  Roche (RHHBY) Announces Positive Data on Hemophilia A Drug Zacks
09:26AM  5 Top Multibagger Biotech Stocks to Buy in the 2nd Half Zacks
Jul-10-17 02:25PM  ETFs with exposure to Enzo Biochem, Inc. : July 10, 2017 Capital Cube
08:38AM  DBV Technologies (DBVT) Worth a Look: Stock Up 5.7% Zacks
Jul-07-17 06:10PM  Endo (ENDP) to Remove Opioid Pain Drug Opana ER from Market Zacks
09:42AM  Shire Completes NDA Filing for Hemophilia Drug with FDA Zacks
09:06AM  Alexion Reportedly Being Investigated by HHS, Shares Slip Zacks
Jul-06-17 08:33AM  Blueprint Medicines (BPMC) Shows Strength: Stock Adds 9.6% in Session Zacks
08:15AM  Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 10.6% Zacks
Jul-05-17 08:33AM  BeiGene (BGNE) Surges: Stock Moves 20.8% Higher Zacks
Jul-04-17 08:25AM  Bayer Starts Phase III Study for Uterine Fibroids' Candidate Zacks
Jun-29-17 08:00AM  Enzo Biochem Reports Delaware Court Ruling Business Wire
Jun-28-17 10:30AM  Esperion's Combo Cholesterol Candidate Enters Phase III Zacks
Jun-27-17 12:41PM  5 Biomedical Stocks That Are Expected To Surge Zacks
09:22AM  Amgen Gets Positive CHMP Opinion for Mimpara Label Expansion Zacks
Jun-22-17 08:58AM  Surging Earnings Estimates Signal Good News for Enzo Biochem (ENZ) Zacks
05:20AM  Enzo Biochem (ENZ) Shares March Higher, Can It Continue? Zacks
Jun-21-17 08:47AM  Looking for a Top Momentum Stock? 3 Reasons Why Enzo Biochem (ENZ) is a Great Choice Zacks
Jun-19-17 03:17PM  ETFs with exposure to Enzo Biochem, Inc. : June 19, 2017 Capital Cube
Jun-12-17 12:59PM  Enzo Biochem, Inc.: Strong price momentum but will it sustain? Capital Cube -5.49%
11:29AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q3, 2017 By the Numbers : June 12, 2017 Capital Cube
08:20AM  Enzo Biochem (ENZ) Looks Good: Stock Jumps 13.3% in Session Zacks
Jun-09-17 01:28PM  ETFs with exposure to Enzo Biochem, Inc. : June 9, 2017 Capital Cube +13.32%
Jun-08-17 04:28PM  Enzo Biochem posts 3Q loss Associated Press
04:10PM  Enzo Biochem Reports Increased Revenues, Improved Operating Results Business Wire
04:00PM  Enzo Biochem Announces New York State Health Department Approval of New Womens Health Diagnostics Business Wire
Jun-02-17 10:00AM  Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2017 Results Friday, June 9, 2017 at 8:30 AM E.T. Business Wire
May-30-17 12:26PM  ETFs with exposure to Enzo Biochem, Inc. : May 30, 2017 Capital Cube
May-19-17 01:51PM  ETFs with exposure to Enzo Biochem, Inc. : May 19, 2017 Capital Cube
May-08-17 04:28PM  ETFs with exposure to Enzo Biochem, Inc. : May 8, 2017 Capital Cube
Apr-27-17 03:57PM  ETFs with exposure to Enzo Biochem, Inc. : April 27, 2017 Capital Cube
Apr-17-17 12:53PM  ETFs with exposure to Enzo Biochem, Inc. : April 17, 2017 Capital Cube +8.81%
08:30AM  Enzo Biochems Clinical Laboratory Named an In-Network Provider to the Fourth Largest National Insurer Business Wire
Apr-13-17 08:58AM  Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe Zacks
Apr-05-17 04:42PM  ETFs with exposure to Enzo Biochem, Inc. : April 5, 2017 Capital Cube
09:10AM  Amedisys (AMED) Poised on Strong Home Health, Risks Remain Zacks
Enzo Biochem, Inc., an integrated diagnostic bioscience company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication levels, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 29 patient service centers in New York and New Jersey; and a free standing ?STAT' or rapid response laboratory in New York City, as well as a full-service phlebotomy department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment is involved in the research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEINER BARRY WPresident, CFO, Treasurer, PAOJan 17Option Exercise2.8830,80288,7101,313,111Jan 19 04:43 PM
RABBANI ELAZARCEO, Chn. of the Brd. and Sec.Jan 17Option Exercise2.8838,505110,8941,867,202Jan 19 04:42 PM
RABBANI ELAZARCEO, Chn. of the Brd. and Sec.Jan 17Sale7.7514,000108,5001,853,202Jan 19 04:42 PM
WEINER BARRY WPresident, CFO, Treasurer, PAOJan 17Sale7.7511,00085,2501,302,111Jan 19 04:43 PM
Perlysky DovDirectorOct 31Option Exercise2.8859,455171,230684,237Nov 02 08:00 PM
BORTZ GREGORY M.DirectorOct 31Option Exercise2.8859,455171,230292,875Nov 02 08:00 PM
BORTZ GREGORY M.DirectorOct 31Sale9.8242,005412,489250,870Nov 02 08:00 PM
Perlysky DovDirectorOct 31Sale9.8142,000412,020642,237Nov 02 08:00 PM
O'Brien James MichaelEVP of FinanceOct 27Option Exercise3.5722,86681,62451,053Oct 30 09:18 PM
O'Brien James MichaelEVP of FinanceOct 27Sale10.2822,866235,06228,187Oct 30 09:18 PM
RABBANI ELAZARCEO, Chn. of the Brd. and Sec.Oct 25Option Exercise3.00159,091477,2732,038,474Oct 27 05:05 PM
WEINER BARRY WPresident, CFO, Treasurer, PAOOct 25Option Exercise3.00112,500337,5001,423,367Oct 27 05:06 PM
WEINER BARRY WPresident, CFO, Treasurer, PAOOct 25Sale10.1154,126547,2141,369,241Oct 27 05:06 PM
RABBANI ELAZARCEO, Chn. of the Brd. and Sec.Oct 25Sale10.0972,401730,5261,966,073Oct 27 05:05 PM
O'Brien James MichaelEVP of FinanceJun 13Sale10.1315,800160,05413,300Jun 15 05:10 PM